Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| SWK Holdings Corporation | SWKH | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 17.23 | 06:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 17.23 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 15.26 - 18.75 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 17.23 | USD |
SWK Holdings Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 312.58M | 12.50M | - | 44.06M | 15.89M | 1.27 | 19.68 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
SWK News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SWKH Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.22 | 17.35 | 16.78 | 17.20 | 4,512 | 0.01 | 0.06% |
| 1 Month | 17.12 | 17.74 | 16.66 | 17.19 | 6,186 | 0.11 | 0.64% |
| 3 Months | 16.34 | 18.488 | 15.92 | 17.20 | 10,666 | 0.89 | 5.45% |
| 6 Months | 16.09 | 18.75 | 15.65 | 17.14 | 8,985 | 1.14 | 7.09% |
| 1 Year | 17.49 | 18.75 | 15.26 | 16.79 | 9,376 | -0.26 | -1.49% |
| 3 Years | 15.93 | 20.4945 | 15.26 | 17.97 | 15,126 | 1.30 | 8.16% |
| 5 Years | 14.00 | 20.4945 | 6.12 | 16.89 | 14,373 | 3.23 | 23.07% |
SWK Description
| SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment. |
